PT Kalbe Farma Tbk - Company Profile
Powered by 
All the sales intelligence you need on PT Kalbe Farma Tbk in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how PT Kalbe Farma Tbk fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with PT Kalbe Farma Tbk.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
PT Kalbe Farma Tbk (Kalbe) provides healthcare solutions to its customers. The company focuses on the development, manufacturing and distribution of pharmaceutical products, nutritional products, and consumer health products. The company provides Health, Medical Services, distribution and Logistics. Its product portfolio comprises branded and unbranded generic drugs, nutritional products and supplements, over-the-counter (OTC) drugs, energy drinks, and medical testing kits, among others. Kalbe is involved in the marketing and trading of medical devices and provides distribution and logistics solutions for pharmaceutical products in Indonesia. It has overseas branches and representative offices in ASEAN countries, Nigeria, the Philippines, and Singapore. The company serves hospitals, pharmacies, and drug stores across Indonesia. Kalbe is headquartered in Jakarta, Indonesia.
Headquarters
Indonesia
Address
Gedung Kalbe Let.Jend Suprato Kav. 4, Jakarta Pusat, Daerah Khusus Ibukota Jakarta Raya, 10510
Website
www.kalbe.co.id
Telephone
62 21 42873888
No of Employees
12,895
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
KLBF (JAK)
Revenue (2024)
$2.1B
8.3%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
13.1%
(2024 vs 2023)
Market Cap*
$2.0B
Net Profit Margin (2024)
XYZ
4.5%
(2024 vs 2023)
* As of and is in US$
PT Kalbe Farma Tbk premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Over The Counter Products | Health and Medical Services | clinimix n9g15e |
| Prescription Pharmaceuticals | Distribution and Logistics | favikal |
| Energy Drinks | ketoconazole tablet ogb hj | |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Corporate Changes/Expansions | In June, the company and GE HealthCare opened the first CT scanner manufacturing facility in Bogor, Indonesia. |
| 2024 | New Products/Services | In December, Kalbe Consumer Health introduced Mixagrip Herbal Greges. |
| 2024 | Corporate Changes/Expansions | In October, PT Global Onkolab Farma launched a radioisotope factory. |
Competitor Comparison
| Key Parameters | PT Kalbe Farma Tbk | PT Tempo Scan Pacific Tbk | PT. Millennium Pharmacon International TBK | PT Pyridam Farma Tbk | PT Prodia Widyahusada Tbk |
|---|---|---|---|---|---|
| Headquarters | Indonesia | Indonesia | Indonesia | Indonesia | Indonesia |
| City | Jakarta Pusat | Jakarta | Jakarta Selatan | Jakarta Selatan | Jakarta Pusat |
| State/Province | Daerah Khusus Ibukota Jakarta Raya | - | Daerah Khusus Ibukota Jakarta Raya | Daerah Khusus Ibukota Jakarta Raya | Daerah Khusus Ibukota Jakarta Raya |
| No. of Employees | 12,895 | 4,480 | - | 2,341 | 2,908 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Bernadette Ruth Irawati Setiady | President Director | Executive Board | 2024 | 64 |
| Kartika Setiabudy | Director | Senior Management | 2023 | 51 |
| Rustam Tan | Head - Internal Audit | Senior Management | 2022 | 56 |
| Mulialie | Director | Senior Management | 2021 | 56 |
| Bernadus Karmin Winata | Director | Senior Management | 2017 | 60 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer